ORMP · NASDAQ · Biotechnology

Oramed Pharmaceuticals (ORMP)

Develops oral formulations for insulin and other therapeutic proteins.

$4.71
vs last close−0.04 (−0.84%)
  1. Oramed Letter to Shareholders

    PRNewsWire